A translational program focused on integrating prevention, screening, early diagnosis and treatment of oral cancer that is aimed at translating research findings into practical care at a population level with minimum delay. The program trains dentists and dental assistants on oral screening as well as assessment; using a BC OCPP-developed risk model to determine probability of progression or regression.
Iris Lin, MSc
Due to the site of the cancer, head and neck cancer (HNCa) survivors face unique challenges and serious health care issues akin to chronic disease as a result of their diagnosis and treatment; yet, the long-term needs of HNCa survivors are not well understood.
Oral cancer is an important global health problem. The disease has a high mortality rate (~63% 5-year survival) mainly due to the advanced stage at which it is diagnosed. In Canada, oral cancer is the ninth most common cancer affecting about 4700 people a year, while in some areas of the world
At the core of the BC OCPP is the OCPL, a globally unique study that follows patients identified with precancer over time with the objective to evaluate clonal/molecular approaches to create an integrated plan for oral dysplasia/cancer assessment and management that is rapid and cost-effective.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.